Table of Content

1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders

2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews With Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation
2.3.1.1. Bottom-Up Approach
2.3.1.2. Top-Down Approach
2.3.1.3. Growth Forecast Approach
2.3.2. Market Share Analysis
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. High Prevalence of Venous Thromboembolism
4.2.2. Rising Incidence of Cancer
4.3. Restraints
4.3.1. Instances of Product Failure and Product Recalls
4.4. Opportunities
4.4.1. Growing Accessibility and Affordability of Treatment Options
4.4.2. Advancements in VTE Diagnosis and Treatment Methods
4.5. Challenges
4.5.1. Lack of Awareness About Venous Thromboembolism

5. Venous Thromboembolism Treatment Market Assessment?by Device
5.1. Overview
5.2. Thrombectomy Devices
5.3. Inferior Vena Cava Filters
5.3.1. Retrievable Filters
5.3.2. Permanent Filters
5.4. Stockings
5.5. Compression Pumps
5.6. Other Devices & Accessories

6. Venous Thromboembolism Treatment Market Assessment?by Application
6.1. Overview
6.2. Deep Vein Thrombosis (DVT)
6.3. Pulmonary Embolism (PE)

7. Venous Thromboembolism Treatment Market Assessment?by End User
7.1. Overview
7.2. Hospitals
7.3. Ambulatory Care Centers
7.4. Other End Users

8. Venous Thromboembolism Treatment Market Assessment?by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific
8.5. Latin America
8.6. Middle East & Africa

9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
9.5.1. Boston Scientific Corporation (U.S.)
9.5.2. Stryker Corporation (U.S.)
9.5.3. Cardinal Health, Inc. (U.S.)
9.5.4. Enovis Corporation (U.S.)
9.5.5. Medtronic plc (Ireland)
9.5.6. Cook Group Incorporated (U.S.)

10. Company Profiles
10.1. ALN Implants chirurgicaux (ALN Surgical Implants)
10.2. AngioDynamics, Inc.
10.3. Argon Medical Devices, Inc.
10.4. ArjoHuntleigh AB
10.5. Boston Scientific Corporation
10.6. Cardinal Health, Inc.
10.7. Cook Group Incorporated
10.8. Koninklijke Philips N.V.
10.9. DS MAREF Co., Ltd
10.10. Enovis Corporation
10.11. LifeTech Scientific Corporation
10.12. Medtronic plc
10.13. Stryker Corporation

11. Appendix
11.1. Available Customization
11.2. Related Reports



List of Figures

Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-Side & Demand-Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Venous Thromboembolism Treatment Market, by Device, 2023 Vs. 2030 (USD Million)
Figure 8 Global Venous Thromboembolism Treatment Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 9 Global Venous Thromboembolism Treatment Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 10 Global Venous Thromboembolism Treatment Market, by Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 Global Venous Thromboembolism Treatment Market, by Device, 2023 Vs. 2030 (USD Million)
Figure 13 Global Venous Thromboembolism Treatment Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 14 Venous Thromboembolism Treatment Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 15 Global Venous Thromboembolism Treatment Market, by Geography, 2023 Vs. 2030 (USD Million)
Figure 16 North America: Venous Thromboembolism Treatment Market Snapshot
Figure 17 Canada: Estimated Number of New Cancer Cases, 2020-2035
Figure 18 Europe: Venous Thromboembolism Treatment Market Snapshot
Figure 19 France: Percentage of Population Aged 65 Years and Above (2016–2022)
Figure 20 France: Prevalence of Chronic Diseases in People Aged 65 And Above (2020)
Figure 21 U.K.: Number of Diabetes And Urogenital, Blood, and Endocrine Disease Cases – DALYs (Disability-Adjusted Life Years), 2017–2020 (In Thousands)
Figure 22 Spain: Estimated Number of New Cancer Cases (2020-2035)
Figure 23 Switzerland: Number of New Cancer Cases Reported (2020–2040)
Figure 24 Asia-Pacific: Venous Thromboembolism Treatment Market Snapshot
Figure 25 Japan: Percentage Share of the Geriatric Population (Aged 65 Years And Above) (2015–2022)
Figure 26 Saudi Arabia: Number of People Aged 65 Years and Above, 2017–2021 (In Thousands)
Figure 27 South Africa: Number of People with Diabetes, 2000–2045 (In Thousands)
Figure 28 Key Growth Strategies Adopted by Leading Players 2020-2023
Figure 29 Venous Thromboembolism Treatment Market: Competitive Benchmarking, by Device
Figure 30 Venous Thromboembolism Treatment Market: Competitive Benchmarking, by Region
Figure 31 Competitive Dashboard: Venous Thromboembolism Treatment Market
Figure 32 Global Venous Thromboembolism Treatment Market Share Analysis, by Key Players (2022)
Figure 33 AngioDynamics, Inc.: Financial Overview (2023)
Figure 34 ArjoHuntleigh Ab: Financial Overview (2022)
Figure 35 Boston Scientific Corporation: Financial Overview (2022)
Figure 36 Cardinal, Inc.: Financial Overview (2022)
Figure 37 Koninklijke Philips N.V.: Financial Overview (2022)
Figure 38 Enovis Corporation: Financial Overview (2022)
Figure 39 LifeTech Scientific Corporation: Financial Overview (2022)
Figure 40 Medtronic plc: Financial Overview (2023)
Figure 41 Stryker Corporation: Financial Overview (2022)

List of Tables

Table 1 Share of Population Aged 65 Years or Above, by Region, 2022 Vs. 2030 Vs. 2050
Table 2 Number of New Cancer Cases, by Type, 2020 Vs. 2030
Table 3 Global Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 4 Global Venous Thromboembolism Treatment Market for Thrombectomy Devices, by Country/Region, 2021–2030 (USD Million)
Table 5 Global Venous Thromboembolism Treatment Market for Inferior Vena Cava Filters, by Type, 2021–2030 (USD Million)
Table 6 Global Venous Thromboembolism Treatment Market for Inferior Vena Cava Filters, by Country/Region, 2021–2030 (USD Million)
Table 7 Global Retrievable Filters Market, by Country/Region, 2021–2030 (USD Million)
Table 8 Global Permanent Filters Market, by Country/Region, 2021–2030 (USD Million)
Table 9 Global Venous Thromboembolism Treatment Market for Stockings, by Country/Region, 2021–2030 (USD Million)
Table 10 Global Venous Thromboembolism Treatment Market for Compression Pumps, by Country/Region, 2021–2030 (USD Million)
Table 11 Global Venous Thromboembolism Treatment Market for Other Devices & Accessories, by Country/Region, 2021–2030 (USD Million)
Table 12 Global Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 13 Global Venous Thromboembolism Treatment Market for Deep Vein Thrombosis (DVT), by Country/Region, 2021–2030 (USD Million)
Table 14 Global Venous Thromboembolism Treatment Market for Pulmonary Embolism (PE), by Country/Region, 2021–2030 (USD Million)
Table 15 Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 16 Global Venous Thromboembolism Treatment Market for Hospitals, by Country/Region, 2021–2030 (USD Million)
Table 17 Global Venous Thromboembolism Market for Ambulatory Care Centers, by Country/Region, 2021–2030 (USD Million)
Table 18 Global Venous Thromboembolism Market for Other End Users, by Country/Region, 2021–2030 (USD Million)
Table 19 Global Venous Thromboembolism Treatment Market, by Country/Region, 2021–2030 (USD Million)
Table 20 North America: Venous Thromboembolism Treatment Market, by Country, 2021–2030 (USD Million)
Table 21 North America: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 22 North America: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 23 North America: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 24 North America: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 25 U.S.: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 26 U.S.: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 27 U.S.: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 28 U.S.: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 29 Canada: Prevalence of Diseases/Conditions in The Geriatric (Age 65 Years And Above) Population (2019–2020)
Table 30 Canada: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 31 Canada: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 32 Canada: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 33 Canada: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 34 Europe: Venous Thromboembolism Treatment Market, by Country/Region, 2021–2030 (USD Million)
Table 35 Europe: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 36 Europe: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 37 Europe: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 38 Europe: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 39 Germany: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 40 Germany: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 41 Germany: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 42 Germany: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 43 France: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 44 France: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 45 France: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 46 France: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 47 U.K.: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 48 U.K.: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 49 U.K.: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 50 U.K.: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 51 Italy: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 52 Italy: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 53 Italy: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 54 Italy: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 55 Spain: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 56 Spain: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 57 Spain: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 58 Spain: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 59 Number of People Aged 56 And Above, by Country, 2012- 2022
Table 60 Estimated Number of New Cancer Cases, by Country, 2020 Vs. 2030
Table 61 RoE: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 62 RoE: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 63 RoE: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 64 RoE: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 65 Asia-Pacific: Venous Thromboembolism Treatment Market, by Country/Region, 2021–2030 (USD Million)
Table 66 Asia-Pacific: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 67 Asia-Pacific: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 68 Asia-Pacific: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 69 Asia-Pacific: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 70 China: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 71 China: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 72 China: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 73 China: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 74 Japan: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 75 Japan: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 76 Japan: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 77 Japan: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 78 India: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 79 India: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 80 India: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 81 India: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 82 RoAPAC: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 83 RoAPAC: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 84 RoAPAC: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 85 RoAPAC: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 86 Latin America: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 87 Latin America: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 88 Latin America: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 89 Latin America: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 90 Middle East & Africa: Venous Thromboembolism Treatment Market, by Device, 2021–2030 (USD Million)
Table 91 Middle East & Africa: Inferior Vena Cava Filters Market, by Type, 2021–2030 (USD Million)
Table 92 Middle East & Africa: Venous Thromboembolism Treatment Market, by Application, 2021–2030 (USD Million)
Table 93 Middle East & Africa: Venous Thromboembolism Treatment Market, by End User, 2021–2030 (USD Million)
Table 94 Recent Developments, by Company (2020–2023)